NCT02689401View on ClinicalTrials.gov

MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Esophageal Cancer
Interventions
DRUG

Ferumoxytol

DEVICE

MRI 3T scanner

Sponsors
All Listed Sponsors
collaborator

AMAG Pharmaceuticals, Inc.

INDUSTRY

lead

Dana-Farber Cancer Institute

OTHER